BCL2 and neoplasm: Thus, similar to our approach for limiting M.tb in a granuloma model, other labs have queried if specifically inhibiting MCL-1 and BCL-2 would limit tumor burden of cells that highly express both BCL-2 and MCL-1 [11, 17–19,36,64–66].